Advanced search
Publication Cover
Cell Cycle Volume 16, 2017 - Issue 18
Submit an article Journal homepage
1,042
Views
12
CrossRef citations to date
0
Altmetric
Report

p53R2 overexpression in cervical cancer promotes AKT signaling and EMT, and is correlated with tumor progression, metastasis and poor prognosis

Chao JiangState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
,
Rui XuDepartment of Internal Medicine, Cancer Center of Guangzhou Medical University, Guangzhou, Guangdong, China
,
Xiao-Xing LiState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, ChinaORCID Iconhttp://orcid.org/0000-0001-8791-7505
ORCID Icon,
Yan-Yan WangState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
,
Wen-Qian LiangState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, ChinaORCID Iconhttp://orcid.org/0000-0002-3762-4672
ORCID Icon,
Ju-Deng ZengState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
,
Shan-Shan ZhangState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
,
Xiao-Yi XuState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
,
Yang YangState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
,
Mei-Yin ZhangState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
,
Hui-Yun WangState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China;Rutgers Cancer Institute of New Jersey and Department of Pharmacology, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ, USACorrespondence[email protected] [email protected]
ORCID Iconhttp://orcid.org/0000-0001-6728-4376
ORCID Icon &
X. F. Steven ZhengState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China;Rutgers Cancer Institute of New Jersey and Department of Pharmacology, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ, USACorrespondence[email protected] [email protected]
 show all
Pages 1673-1682 | Received 24 Mar 2017, Accepted 12 Apr 2017, Published online: 01 Sep 2017

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Huang Bo, Cai Weiyang & Yanjie Zhang. (2017) p53R2 is oncogenic in human cervical cancer. Cell Cycle 16:14, pages 1323-1324.
Read now

Articles from other publishers (11)

Neena George, Poonam Bhandari, Padival Shruptha, Pradyumna Jayaram, Sima Chaudhari & Kapaettu Satyamoorthy. (2023) Multidimensional outlook on the pathophysiology of cervical cancer invasion and metastasis. Molecular and Cellular Biochemistry 478:11, pages 2581-2606.
Crossref
Omid Kiani Ghalesardi, Farhad Zaker, Abbas Ghotaslou, Hassan boustani, Mohammad Reza Rezvani, Jafar Kiani & Minoo Shahidi. (2023) Effect of siRNA-mediated silencing of p53R2 gene on sensitivity of T-ALL cellsto Daunorubicin. Gene 880, pages 147622.
Crossref
Naser Mobarra, Hanieh Gholamalizadeh, Kaed A. Abdulhussein, Sara Raji, Fatemeh Taheri Asl, Mobina Sadat Mirvahabi, Mahdi Rafiee & Reza Pakzad. (2022) Serum level and tumor tissue expression of Ribonucleotide-diphosphate Reductase subunit M2 B: a potential biomarker for colorectal cancer. Molecular Biology Reports 49:5, pages 3657-3663.
Crossref
Wenjing Diao, Qisang Guo, Caiying Zhu, Yu Song, Hua Feng, Yuankui Cao, Ming Du & Huifen Chen. (2020) USP18 promotes cell proliferation and suppressed apoptosis in cervical cancer cells via activating AKT signaling pathway. BMC Cancer 20:1.
Crossref
Mixue Bai, Yingying Che, Kun Lu & Lin Fu. (2020) Analysis of deubiquitinase OTUD5 as a biomarker and therapeutic target for cervical cancer by bioinformatic analysis. PeerJ 8, pages e9146.
Crossref
David G. J. Cucchi, Costa Bachas, Kim Klein, Sander Huttenhuis, Christian M. Zwaan, Gert J. Ossenkoppele, Jeroen M. W. M. Janssen, Gertjan L. Kaspers & Jacqueline Cloos. (2019) TP53 mutations and relevance of expression of TP53 pathway genes in paediatric acute myeloid leukaemia . British Journal of Haematology 188:5, pages 736-739.
Crossref
Fangfang Zhang, Xuelei Ruan, Jun Ma, Xiaobai Liu, Jian Zheng, Yunhui Liu, Libo Liu, Shuyuan Shen, Lianqi Shao, Di Wang, Chunqing Yang, Heng Cai, Zhen Li, Ziyi Feng & Yixue Xue. (2020) DGCR8/ZFAT-AS1 Promotes CDX2 Transcription in a PRC2 Complex-Dependent Manner to Facilitate the Malignant Biological Behavior of Glioma Cells. Molecular Therapy 28:2, pages 613-630.
Crossref
Jianyun Zheng, Jianxin Yu, Min Yang & Li Tang. (2019) Gefitinib suppresses cervical cancer progression by inhibiting cell cycle progression and epithelial‑mesenchymal transition. Experimental and Therapeutic Medicine.
Crossref
Zhuo Ouyang, Minxiu Chen, Jinping Sun & Jianjun Zhai. (2019) Expression and role of hScrib in endometrium, endometriosis, and endometrial adenocarcinoma. Medicine 98:5, pages e14076.
Crossref
Xiuling Liang, Xianfang Xin, Dongmei Qi, Chengyan Fu & Mingde Ding. (2019) Silencing the PIK3CA Gene Enhances the Sensitivity of Childhood Leukemia Cells to Chemotherapy Drugs by Suppressing the Phosphorylation of Akt . Yonsei Medical Journal 60:2, pages 182.
Crossref
Ako Azimi, Maryam Majidinia, Vahid Shafiei-Irannejad, Rana Jahanban-Esfahlan, Yasin Ahmadi, Ansar Karimian, Seyed mostafa Mir, Hadi Karami & Bahman Yousefi. (2018) Suppression of p53R2 gene expression with specific siRNA sensitizes HepG2 cells to doxorubicin. Gene 642, pages 249-255.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.